Skip to content
healthcare.dev
Get a free key

Guaifenesin

NDC 76162-031, Guaifenesin, tablet, extended release, from TOPCO ASSOCIATES LLC.

Product NDC
76162-031
Status
Listed
Labeler
TOPCO ASSOCIATES LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA210453
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76162-031 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
76162-031-56761620031564 BLISTER PACK in 1 CARTON (76162-031-56) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 76162-031 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76162-031 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76162-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.